Latest Clinical Trials
Research indicates that concomitant idiopathic pulmonary fibrosis worsens clinical outcomes in patients with lung cancer.
When it comes to vaccination campaigns, there is an urgent need for message discipline to be strictly maintained. For example, during the COVID-19 pandemic, it was vital that people understood the types of COVID-19 vaccines that have been developed, the rigorous testing process that has been undertaken, and why it is important that all eligible…
Idiopathic pulmonary fibrosis (IPF) and lung cancer are often viewed as 2 separate diseases, each with its own pathophysiology. However, recent studies have suggested they are more alike than previously acknowledged. Lung cancer is one of the leading causes of cancer-related deaths across the globe, and patients with IPF are at a higher risk of…
Environmental scientists have been warning us for a long time that climate change and air pollution are having a negative impact on our health. However, medical research attempting to associate environmental factors with the risk of developing certain diseases is scarce. Why is this? Perhaps medical researchers see environmental science as something outside their field…
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
Various researchers have chronicled how our understanding of idiopathic pulmonary fibrosis has undergone tremendous changes over the years.
Researchers explain why they believe visual analog scales are ideal assessment tools for understanding patients’ experiences.
Rare disease advocates are marking the 40th anniversary of the landmark Orphan Drug Act, which has led to over 1100 approvals for new therapies.
The Alliance for Regenerative Medicine aims to help in the development of safe and effective regenerative therapies that can benefit rare disease patients.
A pulmonary fibrosis foundation and a professional medical association have teamed up to slash the time it takes to diagnose idiopathic pulmonary fibrosis.
An updated set of clinical practice guidelines has been issued for the diagnosis and treatment of idiopathic pulmonary fibrosis in adults.
Rare Care Podcast
Diagnosing and Treating IPF: Insights From Noah Greenspan, DPT, founder of New York City’s Pulmonary Wellness & Rehabilitation Center.
IPF Meeting Coverage